Skip to main content Back to Top
Advertisement

6/23/2016

Heparin Sodium Premixed Bags

Products Affected - Description

    • Heparin Sodium solution for injection, Pfizer, 12,500 unit/250 mL in 5% Dextrose, premixed bag, 24 count, NDC 00409-7794-62
    • Heparin Sodium solution for injection, Pfizer, 20,000 unit/250 mL in 5% Dextrose, premixed bag, 24 count, NDC 00409-7760-03
    • Heparin Sodium solution for injection, Pfizer, 25,000 unit/250 mL in 5% Dextrose, premixed bag, 24 count, NDC 00409-7793-62
    • Heparin Sodium solution for injection, Pfizer, 25,000 unit/500 mL in 5% Dextrose, premixed bag, 24 count, NDC 00409-7761-03

Reason for the Shortage

    • Baxter and BBraun have product available.
    • Hospira states the reason for the shortage is manufacturing delays.

Available Products

    • Heparin Sodium solution for injection, BBraun, 1,000 unit/500 mL in 0.9% Sodium Chloride, premixed bag, 24 count, NDC 00264-9872-10
    • Heparin Sodium solution for injection, BBraun, 20,000 unit/500 mL in 5% Dextrose, premixed bag, 24 count, NDC 00264-9567-10
    • Heparin Sodium solution for injection, BBraun, 25,000 unit/250 mL in 5% Dextrose, premixed bag, 24 count, NDC 00264-9587-20
    • Heparin Sodium solution for injection, BBraun, 25,000 unit/500 mL in 5% Dextrose, premixed bag, 24 count, NDC 00264-9577-10
    • Heparin Sodium solution for injection, Baxter, 1,000 unit/500 mL in 0.9% Sodium Chloride, premixed bag, 18 count, NDC 00338-0431-03
    • Heparin Sodium solution for injection, Baxter, 2,000 unit/1000 mL in 5% Dextrose, premixed bag, 12 count, NDC 00338-0433-04
    • Heparin Sodium solution for injection, Pfizer, 1,000 unit/500 mL in 0.9% Sodium Chloride, premixed bag, 18 count, NDC 00409-7620-03
    • Heparin Sodium solution for injection, Pfizer, 12,500 unit/250 mL in 0.45% Sodium Chloride, premixed bag, 24 count, NDC 00409-7651-62
    • Heparin Sodium solution for injection, Pfizer, 2,000 unit/1000 mL in 0.9% Sodium Chloride, premixed bag, 12 count, NDC 00409-7620-59
    • Heparin Sodium solution for injection, Pfizer, 25,000 unit/250 mL in 0.45% Sodium Chloride, premixed bag, 24 count, NDC 00409-7650-62
    • Heparin Sodium solution for injection, Pfizer, 25,000 unit/500 mL in 0.45% Sodium Chloride, premixed bag, 24 count, NDC 00409-7651-03

Estimated Resupply Dates

    • Hospira has heparin sodium 12,500 unit/250 mL in 5% dextrose and 25,000 unit/250 mL in 5% dextrose premixed bags on long-term back order and the company cannot estimate a release date.
    • All other marketed presentations are available.

Updated

Updated June 23, 2016 by Leslie Jensen, PharmD, Drug Information Specialist. Created February 7, 2008 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.